İbrahim Atakan Geçi̇ci̇

İbrahim Atakan Geçi̇ci̇

Auto-generated profile, based on publicly available information

İbrahim Atakan Geçi̇ci̇

Kırklareli Training and Research Hospital

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Journal of Emergency Medicine Case Reports
Verified
Journal Article
Closed access
OGOya Güven
Oya Güven
LTLale Tuna
Lale Tuna
IGİbrahim Atakan Geçi̇ci̇
İbrahim Atakan Geçi̇ci̇
ZDZeynep Sümeyye Durgun
Zeynep Sümeyye Durgun
ÖIÖmer Işık
Ömer Işık
Introduction: Although the most prominent effect of Corona disease, respiratory disease it disrupts the vascular structure and causes vascular occlusion. Intravascular coagulation, has also begun to be observed in people who have been vaccinated. Therefore, clinicians had to add anti-coagulants or antiaggregants to the treatment. Case Reports: In this article; We will try to present the patient who developed arterial and venous embolism after BioNTech vaccine. These patients without known vascular disease responded well to treatment. Conclusion: The rate of sickness dropped after the vaccine was discovered to be the most effective strategy to protect against Covid-19. It was discovered that vaccinated patients exhibited symptoms similar to corona disease but had a moderate course.